# BRISDELLE
> **NDA204516** · New Drug Application · Sponsor: LEGACY PHARMA · Approved 2013-06-28
## Drug
- **FDA Application Number:** NDA204516
- **Application type:** New Drug Application
- **Brand name:** BRISDELLE
- **Generic name:** PAROXETINE
- **Active ingredients:** PAROXETINE MESYLATE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** LEGACY PHARMA
- **Manufacturer:** Padagis US LLC
- **First approval:** 2013-06-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204516)
---
*AI Analytics · CC0 1.0*